---
title: "Pre-market hot trades in US stocks: Basel Medical pre-market down 14.57%; Cycurion pre-market up 12.25%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297147352.md"
description: "Basel Medical pre-market down 14.57%; Cycurion pre-market up 12.25%; Mercer International pre-market up 72.03%; Meitu Technology pre-market up 59.54%; Volitionrx pre-market up 49.50%"
datetime: "2026-08-27T08:22:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297147352.md)
  - [en](https://longbridge.com/en/news/297147352.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297147352.md)
generator: "portal-rs"
---

# Pre-market hot trades in US stocks: Basel Medical pre-market down 14.57%; Cycurion pre-market up 12.25%

**Popular Pre-Market Trades in US Stocks**

Basel Medical is down 14.57% in pre-market trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Cycurion is up 12.25% in pre-market trading. Based on recent key news:

1.  On August 26, Cycurion announced a 1-for-8 reverse stock split to meet Nasdaq's minimum bid requirements. This move aims to improve the company's operational performance and drive up the stock price.

2.  On August 26, Cycurion's gross margin for the second quarter rose from 6.1% in the same period last year to 29.1%, with net debt reduced by more than half, enhancing market confidence.

3.  On August 26, Cycurion's board approved a $500,000 stock repurchase plan, further boosting investor sentiment. The cybersecurity industry is performing strongly, with significant capital inflow.

**Top Gainers in Pre-Market Trading in US Stocks**

Mercer International is up 72.03% in pre-market trading. Based on recent key news:

1.  On August 26, the Canadian government announced a CAD 20 million financial aid to Mercer Peace River Pulp Ltd., a subsidiary of Mercer International. This funding will be used for modernization, productivity enhancement, and bioenergy expansion and carbon capture preparations, significantly driving up the stock price.

2.  On August 26, Mercer International reported its significant position in the North American and European forest products markets, with annual production capacity including 2.1 million tons of pulp and 1,023 million board feet of lumber, highlighting the company's importance in the industry and further boosting market confidence.

3.  On August 26, technical sentiment signals indicated a sell, but due to government support and the company's strong market position, investor sentiment turned positive, driving up the stock price. The overall industry is performing strongly, with clear policy support.

Meitu Technology is up 59.54% in pre-market trading. Based on recent key news:

1.  On August 26, Meitu Technology released important information through the EDGAR system of the U.S. Securities and Exchange Commission, significantly driving up the stock price. The information is the company's responsibility, showing a positive market response, with the stock price rising 59.54% in pre-market trading. Source: Public Technologies

2.  Recently, the market has shown higher attention to companies with clear support for cash flow and infrastructure, and Meitu Technology's latest disclosures may have enhanced investor confidence, leading to the stock price increase. Source: Public Technologies

3.  Other companies like Liberty Broadband and Centennial Resource Development lack significant updates in the market, leading investors to turn to companies like Meitu Technology with clear information disclosures. Source: Public Technologies The market is more focused on cash flow companies VolitionRx pre-market rose 49.50%. Based on recent key news:

4.  On August 26, VolitionRx transferred its Nu.Q NETs testing to the Sysmex platform, promoting broader commercial agreement negotiations. This move allows for the deployment of sepsis-focused testing on Sysmex analyzers, enhancing licensing prospects with major diagnostic groups. Source: PR Newswire

5.  On August 26, VolitionRx achieved a significant revenue growth of 112% in the first half of the year and reached a milestone of $5 million in the veterinary field. This achievement is attributed to recent collaboration announcements and ongoing licensing discussions with over a dozen global diagnostic companies. Source: PR Newswire

6.  On August 26, VolitionRx is actively engaged in licensing discussions with several global diagnostic and liquid biopsy companies, further solidifying its industry position. Source: PR Newswire The trend of collaboration in the diagnostic industry is significant, with active capital inflow

### Related Stocks

- [BMGL.US](https://longbridge.com/en/quote/BMGL.US.md)
- [CYCU.US](https://longbridge.com/en/quote/CYCU.US.md)
- [MERC.US](https://longbridge.com/en/quote/MERC.US.md)
- [WNW.US](https://longbridge.com/en/quote/WNW.US.md)
- [VNRX.US](https://longbridge.com/en/quote/VNRX.US.md)

## Related News & Research

- [ENvue Medical announces 1-for-12 reverse stock split](https://longbridge.com/en/news/297559591.md)
- [ENvue Medical announces 1-for-12 reverse stock split effective Sept. 1](https://longbridge.com/en/news/297321134.md)
- [Creative Medical Technology Holdings stockholders approved increase in authorized common shares to 100 million](https://longbridge.com/en/news/297556623.md)
- [Shell Upstream chief Costello sells GBP 1.06 million of shares](https://longbridge.com/en/news/297604834.md)
- [Is Coca-Cola’s Q2 Beat And Upgraded Outlook Altering The Investment Case For KO?](https://longbridge.com/en/news/297406357.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**